Rancho Conejo Biotech Area Sidewalks
CI 5664
The Rancho Conejo Biotech Area, located in Newbury Park, north of Hillcrest Drive and along Rancho Conejo Boulevard and Lawrence Drive has segments without sidewalks and crosswalks along the busy industrial and biotech zones. The City plans to provide pedestrian facilities within the Rancho Conejo Biotech Area with the main project objective installing the incomplete segments of sidewalk and to improve pedestrian safety within the project limits.
To improve pedestrian safety, this project will install, within the project limits, incomplete sidewalk segments, construct bioswale to enhance stormwater treatment, install marked crosswalks, and enhanced crosswalk striping and Rectangular Rapid Flashing Beacons (RRFB) on Rancho Conejo Blvd.
Improvements include:
- Construction of incomplete sidewalk segments on Teller Road (Lawrence Drive to Marion Street - approx 1000'), Lawrence Drive (approx 700' north of Hillcrest Drive), Hillcrest Drive (Mitchell Drive to approx 1000' west of Lawrence Drive), and Corporate Center Drive (400' west of Rancho Conejo Boulevard).
- Installation of sidewalks at mid-block on Lawrence Drive, intersection of Hillcrest Drive and Lawrence Drive, and the intersection of Corporate Center Drive and Rancho Conejo Drive.
- Installation of a rapid flashing beacon and advance warning devices across Rancho Conejo Boulevard at Corporate Center Drive.
- Construction of a bioswale on Hillcrest Drive and biodetention on Lawrence Drive to improve stormwater quality.
Timeline and Funding
The design phase is currently in progress with expected completion in Summer 2023. Once the City receives Caltrans approval of the environmental document and issue a right of way certification in Winter 2023, the City will seek the allocation and obligation of federal funds by Summer 2024. Upon the approval of City Council, request for construction bids will be advertised. Construction phase is expected to begin in Fall 2024 and completed in Summer 2025.
$1,593,000 – Federal Covid Relief and Recovery Supplemental Appropriation (CRRSA) Grant
$1,600,000 – General Fund